TTOO stock forecast
Our latest prediction for T2 Biosystems, Inc.'s stock price was made on the Feb. 9, 2018 when the stock price was at 4.28$.
In the short term (2weeks), TTOO's stock price should outperform the market by 0.10%. During that period the price should oscillate between -9.24% and +14.53%.
In the medium term (3months), TTOO's stock price should outperform the market by 1.33%. During that period the price should oscillate between -21.82% and +44.32%.Get email alerts
Create a solid portfolio with TTOO
About T2 Biosystems, Inc.
T2 Biosystems, Inc. engages in the development of proprietary technology platform. It offers the T2 Magnetic Resonance technology, which enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types. It products include T2Bacteria Panel, T2Candida Panel, T2Dx Instrument, AND T2MR Technology. The company was founded by Michael J. Cima, Robert S. Langer Jr., Tyler Jacks, Lee Josephson, W. David Lee, and Ralph Weissleder on April 27, 2006 and is headquartered in Lexington, MA.
At the moment the company generates 7M USD in revenues.
On its last earning announcement, the company reported a loss of -1.36$ per share.
The book value per share is 0.73$
Three months stock forecastFeb. 9, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|